Your browser doesn't support javascript.
loading
Is it safe to continue antithrombotic agents before prostate biopsy?
Tanabe, Kuniaki; Hattori, Tomotaka; Kobayashi, Hirohito; Koike, Kyoko; Maki, Yasuhiro; Arai, Takashi; Otsuka, Toshiaki; Suzuki, Yasutomo; Kondo, Yukihiro; Kawamura, Naoki.
Affiliation
  • Tanabe K; Department of Urology, Nippon Medical School, Tokyo, Japan.
  • Hattori T; Department of Urology, Ebina General Hospital, Kanagawa, Japan.
  • Kobayashi H; Department of Urology, Ebina General Hospital, Kanagawa, Japan.
  • Koike K; Department of Urology, Ebina General Hospital, Kanagawa, Japan.
  • Maki Y; Department of Urology, Ebina General Hospital, Kanagawa, Japan.
  • Arai T; Department of Urology Kitakyushu General Hospital, Fukuoka, Japan.
  • Otsuka T; Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan.
  • Suzuki Y; Department of Urology, Nippon Medical School Chiba Hokusou Hospital, Chiba, Japan.
  • Kondo Y; Department of Urology, Nippon Medical School, Tokyo, Japan.
  • Kawamura N; Department of Urology, Ebina General Hospital, Kanagawa, Japan.
Prostate Int ; 7(2): 78-81, 2019 Jun.
Article in En | MEDLINE | ID: mdl-31384610

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies Language: En Journal: Prostate Int Year: 2019 Document type: Article Affiliation country: Japón Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies Language: En Journal: Prostate Int Year: 2019 Document type: Article Affiliation country: Japón Country of publication: